ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 148 filers reported holding ACORDA THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $756,000 | +35.2% | 1,093,359 | +0.7% | 0.00% | – |
Q3 2020 | $559,000 | -33.5% | 1,086,230 | -5.2% | 0.00% | – |
Q2 2020 | $840,000 | -87.7% | 1,145,305 | -84.4% | 0.00% | – |
Q1 2020 | $6,829,000 | -57.3% | 7,321,920 | -6.6% | 0.00% | -100.0% |
Q4 2019 | $15,991,000 | -28.9% | 7,839,176 | +0.1% | 0.00% | 0.0% |
Q3 2019 | $22,485,000 | -58.2% | 7,834,694 | +11.8% | 0.00% | -50.0% |
Q2 2019 | $53,742,000 | -39.9% | 7,006,848 | +4.2% | 0.00% | -50.0% |
Q1 2019 | $89,373,000 | -14.0% | 6,724,897 | +0.8% | 0.00% | -20.0% |
Q4 2018 | $103,948,000 | -9.4% | 6,671,846 | +14.2% | 0.01% | 0.0% |
Q3 2018 | $114,768,000 | -41.8% | 5,840,738 | -14.9% | 0.01% | -44.4% |
Q2 2018 | $197,035,000 | +28.9% | 6,865,313 | +6.3% | 0.01% | +28.6% |
Q1 2018 | $152,811,000 | +10.3% | 6,461,423 | +0.0% | 0.01% | 0.0% |
Q4 2017 | $138,564,000 | -6.7% | 6,459,742 | +2.9% | 0.01% | 0.0% |
Q3 2017 | $148,511,000 | +17.5% | 6,279,562 | -2.1% | 0.01% | 0.0% |
Q2 2017 | $126,421,000 | -6.3% | 6,417,336 | -0.1% | 0.01% | 0.0% |
Q1 2017 | $134,932,000 | +69452.6% | 6,425,256 | +62573.2% | 0.01% | – |
Q4 2016 | $194,000 | -47.6% | 10,252 | -42.2% | 0.00% | -100.0% |
Q3 2016 | $370,000 | +11.1% | 17,735 | +35.7% | 0.00% | 0.0% |
Q2 2016 | $333,000 | +326.9% | 13,065 | +342.1% | 0.00% | – |
Q1 2016 | $78,000 | +36.8% | 2,955 | +120.7% | 0.00% | – |
Q4 2015 | $57,000 | +96.6% | 1,339 | +21.8% | 0.00% | – |
Q3 2015 | $29,000 | -80.5% | 1,099 | -75.3% | 0.00% | – |
Q2 2015 | $149,000 | -57.7% | 4,446 | -58.0% | 0.00% | – |
Q1 2015 | $352,000 | +278.5% | 10,581 | +363.1% | 0.00% | – |
Q4 2014 | $93,000 | +20.8% | 2,285 | 0.0% | 0.00% | – |
Q3 2014 | $77,000 | +97.4% | 2,285 | +97.7% | 0.00% | – |
Q2 2014 | $39,000 | -98.7% | 1,156 | -98.6% | 0.00% | -100.0% |
Q1 2014 | $3,110,000 | +39.3% | 82,054 | +7.3% | 0.01% | +25.0% |
Q4 2013 | $2,233,000 | +190.4% | 76,454 | +239.8% | 0.00% | +300.0% |
Q3 2013 | $769,000 | +7.7% | 22,499 | +3.9% | 0.00% | 0.0% |
Q2 2013 | $714,000 | – | 21,648 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |